Nrx alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against nrx pharmaceuticals, inc. and encourages investors to contact the firm

New york--(business wire)-- #class--bragar eagel & squire, p.c., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp, nrxpw) in the united states district court for the district of delaware on behalf of all persons and entities who purchased or otherwise acquired nrx securities between june 1, 2021 and november 4, 2021, both dates inclusive (the “class period”). inve
NRXP Ratings Summary
NRXP Quant Ranking